Impax Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Impax Asset Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$13.4M	Hold	64,927	–	–	0.8%	58
2018 Q1	$13.4M	Sell	64,927 -32,800	-34%	-$6.88M	0.77%	56
2017 Q4	$18.6M	Sell	97,727 -17,800	-15%	-$3.41M	1.07%	36
2017 Q3	$21.9M	Hold	115,527	–	–	1.25%	21
2017 Q2	$20.2M	Hold	115,527	–	–	1.14%	29
2017 Q1	$17.7M	Hold	115,527	–	–	0.99%	37
2016 Q4	$16.3M	Sell	115,527 -19,473	-14%	-$2.87M	0.93%	47
2016 Q3	$21.5M	Sell	135,000 -4,189	-3%	-$646K	1.23%	21
2016 Q2	$20.6M	Sell	139,189 -14,962	-10%	-$2.21M	1.19%	24
2016 Q1	$21.8M	Buy	154,151 +115,000	+294%	+$15.4M	1.17%	26
2015 Q4	$5.55M	Buy	39,151 +7,077	+22%	+$944K	0.31%	94
2015 Q3	$3.92M	Sell	32,074 -1,822	-5%	-$237K	0.23%	101
2015 Q2	$4.4M	Buy	33,896 +247	+0.7%	+$32.2K	0.24%	108
2015 Q1	$4.52M	Buy	33,649 +3,615	+12%	+$466K	0.25%	105
2014 Q4	$3.76M	Buy	30,034 +227	+0.8%	+$27.6K	0.22%	92
2014 Q3	$3.63M	Buy	29,807 +1,423	+5%	+$173K	0.24%	84
2014 Q2	$3.35M	Sell	28,384 -6,410	-18%	-$754K	0.21%	89
2014 Q1	$4.18M	Sell	34,794 -658	-2%	-$78.2K	0.27%	76
2013 Q4	$3.95M	Sell	35,452 -3,736	-10%	-$371K	0.25%	77
2013 Q3	$3.61M	Sell	39,188 -281	-0.7%	-$25.4K	0.24%	80
2013 Q2	$3.34M	Buy	+39,469	New	+$3.29M	0.23%	89

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Impax Asset Management's TMO Position: Q2 2018 in Review

Impax Asset Management held its Thermo Fisher Scientific (TMO) position steady in Q2 2018 at 64,927 shares worth $13.4M. The position accounts for 0.8% of the portfolio, ranked #58.

Impax Asset Management first reported a position in TMO in Q2 2013 and has held it in 21 quarters since. The position peaked at $21.9M in Q3 2017. 1,323 funds tracked by Wall St. Rank hold TMO as of Q2 2018.

Impax Asset Management held 64,927 shares of Thermo Fisher Scientific worth $13.4M as of Q2 2018.
Impax Asset Management left its Thermo Fisher Scientific share count unchanged in Q2 2018.
Thermo Fisher Scientific made up 0.8% of Impax Asset Management's portfolio in Q2 2018, its #58 holding.
Impax Asset Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 21 quarters since.
Impax Asset Management's Thermo Fisher Scientific position peaked at $21.9M in Q3 2017.
1,323 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2018.

Based on Impax Asset Management's 13F filing for Q2 2018, filed 14 Aug 2018.